Pancreas Transplantation at a Single Latin-American Center; Overall Results with Type 1 and Type 2 Diabetes Mellitus

GONDOLESI, G.E.; MOS, F.A.; GUTIÉRREZ, L.M.; RABIN, G.E.; BARROS SCHELOTTO, P.H.L.; AGUIRRE, N.F.; PEDRAZA, N.F.; FRAGUAS, H.; MUSSO, C.; RAFFAELE, P.M.; RAMISCH, D.A.; FORTUNATO, M.R.; MARRUGAT, R.; FARINELLI, P.A.

TRANSPLANTATION PROCEEDINGS

ELSEVIER SCIENCE INC

Año: 2018 vol. 50 p. 1475 - 1481

0041-1345

Background: Simultaneous pancreas-kidney transplantation (SPK) has become the treatment of choice for type 1 diabetes mellitus (T1DM) patients with chronic renal failure. Type 2 diabetes mellitus (T2DM), was once considered to be a contraindication for pancreas transplantation; however, it has been accepted as a new indication, under strict criteria. Although favorable results have increase the indication for T2DM in developed countries, there have been no reports of long-term results for this indication from Latin American centers. Methods: From April 2008 to March 2016, patients receiving SPK or pancreas transplant alone (PTA) for T2DM were included and compared with T1DM recipients. Variables were compared between groups with the use of χ2 and t tests; Kaplan-Meier with log rank was used for patient and graft survivals; P